Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) EBIT Margin (2019 - 2025)

Historic EBIT Margin for Korro Bio (KRRO) over the last 6 years, with Q3 2025 value amounting to 1764.86%.

  • Korro Bio's EBIT Margin changed N/A to 1764.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 1282.04%, marking a year-over-year change of. This contributed to the annual value of 4047.12% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Korro Bio's EBIT Margin is 1764.86%.
  • Korro Bio's EBIT Margin's 5-year high stood at 7072.54% during Q1 2023, with a 5-year trough of 1863.15% in Q2 2025.
  • Its 4-year average for EBIT Margin is 118.41%, with a median of 981.18% in 2025.
  • Data for Korro Bio's EBIT Margin shows a peak YoY increase of -1129100bps (in 2021) and a maximum YoY decrease of -3564400bps (in 2021) over the last 5 years.
  • Quarter analysis of 4 years shows Korro Bio's EBIT Margin stood at 185.65% in 2021, then skyrocketed by 3910bps to 7072.54% in 2023, then crashed by -114bps to 1014.53% in 2024, then tumbled by -74bps to 1764.86% in 2025.
  • Its EBIT Margin was 1764.86% in Q3 2025, compared to 1863.15% in Q2 2025 and 981.18% in Q1 2025.